A Retrospective Study on Infusion-Related Reactions to Rituximab in a Heterogeneous Pediatric Population

Abstract

Rituximab infusion-related reactions in a heterogeneous pediatric population were frequent on first infusion, but rare in subsequent ones. Overall, these reactions were mild and manageable through pharmacological treatment. Patients with an elevated absolute lymphocyte count before infusion were at greater risk for an infusion-related reaction.